MX2020012237A - Proteccion de moleculas biologicamente activas durante esterilizacion por radiacion. - Google Patents

Proteccion de moleculas biologicamente activas durante esterilizacion por radiacion.

Info

Publication number
MX2020012237A
MX2020012237A MX2020012237A MX2020012237A MX2020012237A MX 2020012237 A MX2020012237 A MX 2020012237A MX 2020012237 A MX2020012237 A MX 2020012237A MX 2020012237 A MX2020012237 A MX 2020012237A MX 2020012237 A MX2020012237 A MX 2020012237A
Authority
MX
Mexico
Prior art keywords
biologically active
biological
radiation
active molecules
sterilization
Prior art date
Application number
MX2020012237A
Other languages
English (en)
Spanish (es)
Inventor
Jeff Boyle
HU Paul Q
Nadia Patrice Allen
Jenny Louise Howard
Original Assignee
Qiagen Sciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qiagen Sciences Llc filed Critical Qiagen Sciences Llc
Publication of MX2020012237A publication Critical patent/MX2020012237A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A61L2/081—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A61L2/087—Particle radiation, e.g. electron-beam, alpha or beta radiation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2020012237A 2018-05-18 2019-05-17 Proteccion de moleculas biologicamente activas durante esterilizacion por radiacion. MX2020012237A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862673671P 2018-05-18 2018-05-18
PCT/US2019/032885 WO2019222638A1 (en) 2018-05-18 2019-05-17 Protection of biologically active molecules during radiation sterilization

Publications (1)

Publication Number Publication Date
MX2020012237A true MX2020012237A (es) 2021-03-25

Family

ID=66770587

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020012237A MX2020012237A (es) 2018-05-18 2019-05-17 Proteccion de moleculas biologicamente activas durante esterilizacion por radiacion.

Country Status (9)

Country Link
US (1) US20210260225A1 (https=)
EP (1) EP3793621A1 (https=)
JP (2) JP7487184B2 (https=)
KR (2) KR102774917B1 (https=)
CN (1) CN112135641A (https=)
AU (2) AU2019269671B2 (https=)
MX (1) MX2020012237A (https=)
SG (1) SG11202009795PA (https=)
WO (1) WO2019222638A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114621467B (zh) * 2022-05-17 2022-07-29 天新福（北京）医疗器材股份有限公司 一种无菌自固化胶原蛋白修复凝胶及其制备方法
CN115611978B (zh) * 2022-11-21 2023-03-07 成都奇璞生物科技有限公司 一种辐照保护剂在制备胶原蛋白产品中的用途

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2649224B2 (ja) * 1987-02-25 1997-09-03 旭メディカル 株式会社 体液処理装置の滅菌方法および滅菌された体液処理装置
US6551794B1 (en) * 1995-11-09 2003-04-22 E. R. Squibb & Sons, Inc. Stable biotinylated biomolecule composition
DE69723243T2 (de) * 1996-02-05 2004-04-22 Asahi Medical Co. Ltd. Sterilisationsschutzmittel und verfahren zur sterilisation
US5730933A (en) * 1996-04-16 1998-03-24 Depuy Orthopaedics, Inc. Radiation sterilization of biologically active compounds
US20030012687A1 (en) * 2000-03-23 2003-01-16 Macphee Martin J. Methods of sterilizing biological materials
US20040086420A1 (en) 2000-03-23 2004-05-06 Macphee Martin J. Methods for sterilizing serum or plasma
EP1299131A4 (en) * 2000-03-23 2003-06-18 Clearant Inc METHODS FOR STERILIZING BIOLOGICAL MATERIALS
US6682695B2 (en) * 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
US6696060B2 (en) * 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
US6946098B2 (en) 2001-08-10 2005-09-20 Clearant, Inc. Methods for sterilizing biological materials
US20030031584A1 (en) 2001-08-10 2003-02-13 Wilson Burgess Methods for sterilizing biological materials using dipeptide stabilizers
US7252799B2 (en) * 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
US6749851B2 (en) * 2001-08-31 2004-06-15 Clearant, Inc. Methods for sterilizing preparations of digestive enzymes
EP1415669A1 (en) * 2002-09-19 2004-05-06 Aventis Behring GmbH Process for sterilization of protein containing biological compositions
US20050069453A1 (en) 2003-09-29 2005-03-31 Ren-Yo Forng Methods for sterilizing preparations of urokinase
US20050175630A1 (en) * 2003-12-23 2005-08-11 Eyal Raz Immunogenic compositions and methods of use thereof
GB0626021D0 (en) * 2006-12-29 2007-02-07 Insense Ltd The stabilisation of proteins
US8304439B1 (en) * 2007-10-12 2012-11-06 Politechnika Lodzka Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing radiation-induced damage
EP2236520A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Stabilizing composition for immobilized biomolecules
EP2236617A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Methods of terminal sterilization of biofunctional compositions
US8999720B2 (en) * 2011-11-17 2015-04-07 Medtronic Minimed, Inc. Aqueous radiation protecting formulations and methods for making and using them
US20180055958A1 (en) * 2015-03-12 2018-03-01 Sanyo Chemical Industries, Ltd. Method for producing protein composition, and protein composition
US20180055822A1 (en) * 2015-03-13 2018-03-01 Repoceuticals Aps Melatonin for Preventing and Treating Radiation Cystitis
US20160354500A1 (en) * 2015-06-02 2016-12-08 Medtronic Minimed, Inc. Protective agents against e-beam irradiation for proteins in optical sensing chemistry
EP3478283A4 (en) * 2016-06-29 2020-07-22 Menlo Therapeutics Inc. USE OF NEUROKININ-1 ANTAGONISTS IN THE TREATMENT OF A VARIETY OF PRURITIUS CONDITIONS
WO2019166003A1 (zh) * 2018-03-02 2019-09-06 郑州大学 14-脱氧-11,12-脱氢-8,12-环氧或7,8-烯-穿心莲内酯及其15位取代衍生物和用途

Also Published As

Publication number Publication date
SG11202009795PA (en) 2020-12-30
CN112135641A (zh) 2020-12-25
AU2019269671A1 (en) 2020-10-22
JP7487184B2 (ja) 2024-05-20
KR20250030028A (ko) 2025-03-05
WO2019222638A1 (en) 2019-11-21
EP3793621A1 (en) 2021-03-24
US20210260225A1 (en) 2021-08-26
AU2025202786A1 (en) 2025-05-08
CA3096717A1 (en) 2019-11-21
KR20210013553A (ko) 2021-02-04
AU2019269671B2 (en) 2025-01-30
JP2024073470A (ja) 2024-05-29
KR102774917B1 (ko) 2025-03-04
BR112020021358A2 (pt) 2021-01-19
JP2021524362A (ja) 2021-09-13

Similar Documents

Publication Publication Date Title
CL2022000250A1 (es) Molécula de unión al antígeno multiespecífica que tiene actividad de sustitución de la función de cofactor del factor viii de coagulación de sangre (fviii) y formulación farmacéutica que contiene tal molécula como ingrediente activo (divisional de la solicitud n°202000767)
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
AR107014A1 (es) Formulación farmacéutica acuosa
CL2018002825A1 (es) Vacuna contra vrs
CL2020002252A1 (es) Formulación oftálmica.
PE20241346A1 (es) Vectores del factor viii del virus adeno-asociado, particulas viricas asociadas y formulaciones que los comprenden
CY1117941T1 (el) Υψηλης συγκεντρωσης φapμαkeytika σκευασματα που περιλαμβανουν το αντισωμα κatα cd20
JP2017222654A5 (https=)
MX2020005857A (es) Formulaciones de composiciones de vacuna contra el virus del dengue.
BR112021019520A2 (pt) Composição farmacêutica, método para tratar a síndrome de hunter e uso de uma composição farmacêutica
PE20220017A1 (es) Inhibidores del kcnt1 y metodos de uso
CL2019001049A1 (es) Vacuna contra parvovirus porcino.
AR092470A1 (es) Formulaciones acuosas estables de adalimumab
MX2024001620A (es) Composiciones estabilizadas de radionucleidos y sus usos.
AR105712A1 (es) Composiciones de insulina de rápida acción
SA521421715B1 (ar) تركيبات سيماجلوتيد ثابتة واستخداماتها
MX2020012237A (es) Proteccion de moleculas biologicamente activas durante esterilizacion por radiacion.
EA200970274A1 (ru) Способы введения гипогликемических средств с длительным действием
CL2022001035A1 (es) Composiciones y métodos para minimizar la pérdida de proteínas a concentraciones de proteínas bajas
MX2019000235A (es) Eliminacion de la cistina mediada por enzimas humanas.
EP4541380A3 (en) Stable, concentrated radionuclide complex solutions
MX2024002249A (es) Uso de glutamina sintetasa para tratar hiperamonemia.
MX2016012447A (es) Formulaciones de factor ix liofilizadas.
AR092691A1 (es) Composicion farmaceutica que comprende rebamipida
AR098569A1 (es) Compuesto químico agrícola y hortícola, método para el control de enfermedades de las plantas, y producto para el control de enfermedades de las plantas